Transcode Therapeutics, Inc. · NASDAQ:RNAZ
YA II PN, Ltd. reported a 9.90% stake in Transcode Therapeutics, Inc. (Schedule 13G)
Event Apr 15, 2026 · Filed Apr 20, 2026
YA II PN, Ltd. reported a 9.90% stake in Transcode Therapeutics, Inc., 101,772 shares, as a passive investor on Apr 15, 2026. Filed Apr 20, 2026 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 101,772
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| YA II PN, Ltd. | 9.90% | 101,772 |
| YA Global Investments II (U.S.), LP | 9.90% | 101,772 |
| Yorkville Advisors Global, LP | 9.90% | 101,772 |
| Yorkville Advisors Global II, LLC | 9.90% | 101,772 |
| YAII GP, LP | 9.90% | 101,772 |
| YAII GP II, LLC | 9.90% | 101,772 |
| Mark Angelo | 9.90% | 101,772 |
| SC-Sigma Global Partners, LP | 9.90% | 101,772 |
Source
Related
- Transcode Therapeutics, Inc.
- YA II PN, Ltd.
- Transcode Therapeutics, Inc. shareholders
- Form 4 · CK Life Sciences Intl (Holdings) Inc · Aug 5, 2026
- Schedule 13D/A · CK Life Sciences Intl (Holdings) Inc · Aug 3, 2026
- Schedule 13G · Daniel Eduardo Katzman · Jul 28, 2026
- Schedule 13G · Elena Rosa Braci · Jul 28, 2026
- Schedule 13G · Unleash Immuno Oncolytics, Inc. · Jul 28, 2026